Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s95, 2020. DOI: 10.25251/skin.4.supp.95. Disponível em: https://skin.dermsquared.com/skin/article/view/1065. Acesso em: 31 oct. 2025.